Table 7.
Days required for symptomatic recovery in both male and female patients, Bangladesh, 2020.
| Variable | Group | 1–7 days | 8–14 days | 15–21 days | 22–28 days | More than 28 days | χ2 (p-value) |
|---|---|---|---|---|---|---|---|
| Total | N = 439 | 16 (3.6%) | 233 (53.1%) | 136 (31%) | 7 (1.6%) | 47 (10.7%) | – |
| Gender | Male (n = 303) | 9 (3.0%) | 152 (50.2%) | 106 (35.0%) | 3 (1.0%) | 33 10.90% | 10.157 (0.071) |
| Female (n = 136) | 7 (5.1%) | 81 (59.6%) | 30 (22.1%) | 4 (2.9%) | 14 (10.3%) | ||
| Age | ≤40 Yrs (n = 318) | 12 (3.8%) | 183 (57.5%) | 81 (25.5%) | 5 (1.6%) | 37 (11.6%) | 16.890 (0.005) |
| >40 Yrs (n = 121) | 4 (3.3%) | 50 (41.3%) | 55 (45.5%) | 2 (1.7%) | 10 (8.3%) | ||
| Comorbidity | Yes (n = 115) | 4 (3.5%) | 41 (36.0%) | 51 (44.7%) | 4 (3.5%) | 14 (12.3%) | 23.638 (0.000) |
| No (n = 324) | 12 (3.7%) | 192 (59.1%) | 85 (26.2%) | 3 (0.9%) | 33 (10.2%) |
Values are expressed as frequency and % response of the final respondents. The percentage was calculated considering the samples in the individual groups. Pearson's chi-squared test was applied to observe the association of the gender, age, and comorbidity in the complete recovery of all COVID-19 associated symptoms. P < 0.05 was considered statistically significant.